glp-3 vs retatrutide New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats glucose control Today, we shared new Color:Silk Metalic Blue

glp-3 vs retatrutide New Phase 3 data just dropped 👀 Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats glucose control Today, we shared new Color:Silk Metalic Blue

Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more at our link in bio.

“From this study, we can’t definitively say this is the reason that people taking GLP-1 medications drink less, but it’s adding to this body of evidence of what the mechanism is.”

glucose control

Color:Silk Metalic Blue

Choosing the right clinic is just as important as choosing the right treatment plan